Mark A. Goldsmith - President and Chief Executive Officer, Director at Revolution Medicines, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and Chief Executive Officer, Director
Stock Symbol
RVMD on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Mark A. Goldsmith - trading volume in the past year for Revolution Medicines, Inc.

Holdings reported by Mark A. Goldsmith for Revolution Medicines, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 465,604 $17.4 M $37.39 Jun 17, 2024 Trust
Common Stock 311,885 $11.7 M $37.39 Jun 17, 2024 Direct
Stock Option (Right to Buy) 316,229 Jun 3, 2024 Direct Common Stock

Transactions reported by Mark A. Goldsmith for Revolution Medicines, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership